Activating mutations for the Met tyrosine kinase receptor in human cancer

Recently, mutations in the Met tyrosine kinase receptor have been identified in both hereditary and sporadic forms of papillary renal carcinoma. We have introduced the corresponding mutations into the met cDNA and examined the effect of each mutation in biochemical and biological assays. We find tha...

Descripció completa

Dades bibliogràfiques

Publicat a:	Proc Natl Acad Sci U S A
Autors principals:	Jeffers, Michael, Schmidt, Laura, Nakaigawa, Noboru, Webb, Craig P., Weirich, Gregor, Kishida, Takeshi, Zbar, Berton, Vande Woude, George F.
Format:	Artigo
Idioma:	Inglês
Publicat:	National Academy of Sciences 1997
Matèries:	Biological Sciences
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC23495/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9326629/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.94.21.11445
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!